Background and Objectives: The degree of port wine stain (PWS) blanching following pulsed dye laser (PDL) therapy remains variable and unpredictable. Because of the limitations of current PDL therapy, alternative treatment approaches should be explored. The objective was to evaluate a novel methodology for selective vascular damage, combined photodynamic (PDT) and photothermal (PDL) treatment, using the in vivo chick chorioallantoic membrane (CAM) model. Study Design/Materials and Methods: Thirty microliters of benzoporphyrin derivative monoacid ring A (BPD) solution was administered intraperitoneally into chick embryos at day 12 of development. Study groups were: (1) control (no BPD, no light); (2) BPD alone; (3) continuous wave irradiation (CW) alone (576 nm, 60 mW/cm 2 , 125 seconds); (4) CW þ PDL; (5) BPDþPDL; (6) PDT (BPDþCW); (7) PDL alone (585 nm, 4 J/cm 2 ); and (8) PDTþPDL (BPD þ CW followed immediately by PDL). Vessels were videotaped prior to, and at 1 hour postintervention and then assessed for damage based on the following scale: 0, no damage; 1, coagulation; 1.5, vasoconstriction; 2.0, coagulationþvasoconstriction; 2.5, angiostasis; 3.0, hemorrhage. Damage scores were weighted by vessel ''order.'' Results: PDT þ PDL resulted in significantly (P < 0.01) more severe vascular damage than was observed in any other study group: 127% more than PDT, 47% more than PDL alone. Conclusions: PDT þ PDL is a novel and promising approach for selective vascular damage and may offer a more effective method for treatment of PWS and other vascular skin lesions.
INTRODUCTION
Pulsed dye laser (PDL) treatment of port wine stain (PWS) produces reasonably good results in some patients because of its ability to destroy selectively dermal blood vessels. Yellow light emitted by a PDL (pulse duration $1 millisecond) is preferentially absorbed by hemoglobin in PWS blood vessels and, after being converted to heat, causes thermal damage to the vessel wall and thrombosis [1] [2] [3] . The degree of PWS blanching following PDL therapy is variable and unpredictable and less than 20% of patients achieve complete blanching [4, 5] , even after multiple treatments (5-30 or more). One factor limiting therapeutic efficacy is the inability of PDL to destroy microvessels (diameter (D) <20 mm) [6] , which contribute significantly to the clinical appearance of PWS lesions. Because of the limited patient response to current PDL therapy, alternative treatment approaches should be explored.
Photodynamic therapy (PDT) has been evaluated for the clinical management of an array of human tumors [7] . Briefly, a photosensitizing drug is administered to the patient and, after a pre-selected time interval, the tissuelocalized photosensitizer is exposed to light at a wavelength absorbed by the photosensitizer. Excited photosensitizer molecules subsequently react with substrates to generate short-lived highly reactive species, including singlet molecular oxygen, which cause irreversible damage to biologically important intracellular structures.
Despite the demonstrated propensity of PDT to destroy the tumor vascular compartment [8] [9] [10] , PDT has been applied only rarely for treatment of PWS [11] [12] [13] . While reasonable success was achieved in terms of PWS blanching, skin necrosis resulted when blue light was used which might be attributed to the high light intensity used [11] . Skin necrosis similarly resulted with the use of red light, presumably because of the deep penetration of wavelengths greater than 600 nm [12] . Further, the photosensitizers utilized in these earlier studies resulted in 15-30 days of light sensitivity.
By careful selection of photosensitizer and wavelength for laser irradiation, PDT injury can be localized to vessels at a desired depth, allowing effective treatment of vascular lesions without injury to the overlying skin. In the present study, we investigate the suitability of benzoporphyrin derivative monoacid ring A (BPD), a second-generation, vascular-specific photosensitizer [14] [15] [16] [17] [18] . BPD is expected to be an excellent photosensitizer for PWS treatment based on the following characteristics: (1) vascular compartmentalization [14] [15] [16] [17] ; (2) proven safety and efficacy in humans [19, 20] ; (3) photosensitivity of relatively short duration (1-5 days depending on dose administered) [20] ; and (4) presence of an absorption peak in the desired yellow wavelength range. BPD has a strong absorption band at l ¼ 576 nm (molar extinction coefficient e ¼ 15,000 M À1 cm À1 ), in addition to its main absorption peak at l ¼ 690 nm (e ¼ 30,000 M À1 cm À1 ) [14] . Hemoglobin, the targeted chromophore in PWS treatment, also has an absorption peak in the yellow spectral region. Further, yellow light has a penetration depth of <1,000 mm, which will confine therapeutic effects to the upper dermis and targeted PWS vessels.
While either PDT or PDL therapy alone can be used for treatment of vascular lesions, each has its limitations. By combining PDT-induced photochemical and PDL-induced photothermal injuries, an enhanced effect might be achieved leading to optimized selective vascular injury and, ultimately, improved PWS blanching [21] . The combination of PDT and PDL is a novel use of these modalities and offers exciting therapeutic potential. Sub-therapeutic PDT, using yellow light absorbed by BPD (l ¼ 576 nm), should make PWS blood vessels more vulnerable to subsequent PDL irradiation by heating the pre-treated vessels compromised by PDT [22] . Use of yellow light for both PDT and PDL confines therapeutic effects to the upper 1,000 mm of the dermis, containing ectatic PWS venules, while reducing risk of possible skin infarction, which could result from destruction of the deeper vascular plexus.
We report enhanced vascular injury achieved by combining PDT with PDL using the in vivo chick chorioallantoic membrane (CAM) model, as previously used for studying vascular effects of BPD-PDT [23] [24] [25] or PDL [26] [27] [28] alone.
MATERIALS AND METHODS

CAM Model
The CAM is an established in vivo system for studying laser induced microvascular effects [23] [24] [25] [26] [27] [28] . The CAM consists of a thin, three-dimensional vascular network located in the chick mesoderm, a transparent matrix that does not significantly absorb or scatter incident visible radiation. It allows direct observation of blood flow, with real-time inspection and video documentation, enabling identification of pre-capillary arterioles (A), and postcapillary venules (V) [29, 30] .
The extensive CAM microvascular network ( Fig. 1 ) is characterized according to the following branching pattern [29] . Capillaries (D < 20 mm) are barely observable at the magnification used (70Â); they are defined as order-0 vessels. A1 and V1 designate, respectively, arterioles and venules of order-1, with D ¼ 20-50 mm. The convergence of two order-1 vessels is assigned as an order-2 vessel, A2 or V2, with D ¼ 60-90 mm. Similarly, two order-2 vessels form an order-3 vessel, A3 or V3, with D > 100 mm. Arterial (An) and venous (Vn) trees inside a selected area to be irradiated were considered independent observables.
CAM Preparation
Fertilized white Leghorn chicken eggs were placed in a hatching incubator with hourly tilting, set at 388C and 60% humidity. At day 4 of embryonic age (EA 4), 4 ml of albumin were aspirated with a 20-G needle, through a hole drilled at the narrow apex, to create a false air sac. At EA 7, a 20 mm diameter opening was cut into the shell and covered with a sterile Petri dish; incubation was continued in a static incubator adjusted to 388C and 70% humidity. At EA 12, when CAM vasculature was fully developed, a Teflon Oring (6 mm inner diameter, 1.4 mm annular width) was placed aseptically on a well-vascularized site of the CAM, situated above the yolk sac for improved visibility. The Teflon O-ring covered an area of 30 mm 2 that typically contained some 100 vessels of various diameters [23, 26, 27] and provided a baseline on the video record.
BPD Administration
BPD (Verteporfin 1 , QLT, Vancouver, BC, Canada) liposomal powder was reconstituted in water, 2 mg/ml. A working solution of 0.125 mg/ml was prepared by diluting the stock preparation with 5% dextrose [23, 24] , protected from light and used within 4 hours of preparation.
BPD (30 ml containing $4 mg/CAM, i.e., 1 mg/kg wet weight of the embryo) was administered intraperitoneally (IP) into the chick embryo using a Hamilton syringe with a 30-G needle [24] . Sterile blackened Petri dishes were placed over the eggshell openings and further manipulations performed in subdued light. 
CW Laser Irradiation
A diffused beam, CW argon pumped-dye laser (Lumenis, Santa Clara, CA) tuned to 576 nm irradiated the area inside the Teflon O-ring, using a power density of 60 mW/cm 2 for 125 seconds, yielding a total radiant exposure of 7.5 J/cm 2 . This value is higher than used in previous experiments, 5 J/ cm 2 [24] , because the absorption coefficient of BPD at 576 nm (15,000 M À1 cm
À1
) is lower than that at 690 nm (30,000 M À1 cm
) [14] . The radiant exposure used in the present study is, however, significantly lower than that reported for 440 nm irradiation [25] after normalizing for BPD absorption.
PDL Irradiation
A 585 nm PDL (ScleroPlus TM , Candela, Wayland, MA) with a 1.5 milliseconds pulse duration, with which photothermal effects on the CAM vasculature have been determined previously [26] [27] [28] , irradiated the area inside the Teflon O-ring at 4 J/cm 2 , using a 7 mm diameter spot.
Photodynamic Therapy
Ten minutes after BPD administration (Dt 1 ), CW irradiation was performed as described above using a power density of 60 mW/cm 2 for 125 seconds, yielding a total radiant exposure of 7.5 J/cm 2 .
Study Groups
The following intervention groups were studied (Table 1) 
Video Microscopic Documentation
Immediately prior to BPD administration, the CAM area was videotaped with a CCD color camera (Sony, model DXC-101) mounted on a stereomicroscope (Olympus, model SZH), using oblique illumination provided by a cold white fiberoptic light guide (Fiber-Lite, Dolan-Jenner, Lawrence, MA). This enabled identification of vessel topography.
Vessel type (A or V) was identified by direction of blood flow. At 1 hour post-irradiation, the CAM area inside the O-ring was videotaped again. Videotapes were analyzed off-line for quantification of vascular damage. Total magnification on the color monitor (Sony, model KV-1393R) was 70Â.
Damage Assessment
Vessels were assessed for damage score based on the following scale [23, 24] : 0, no damage; 1, coagulation; 1.5, vasoconstriction; 2.0, coagulation þ vasoconstriction; 2.5, angiostasis; 3.0, hemorrhage. These scores were multiplied by the vessel ''order'' [29] as follows: order-1 (D ¼ 20-50 mm), order-2 (D ¼ 60-90 mm), or order-3 (D > 100 mm) yielding weighted scores of 0-3, 0-6, or 0-9, respectively.
Each egg was given one weighted score for each vessel type (whether A or V) based on the highest damage observed. A composite vessel damage score was determined for each egg by selecting the highest damage score (A or V). The mean damage scores AE standard errors of the mean (SEM) were evaluated for each vessel type (A, V, or composite), in each study group. Table 2 provides the mean weighted damage scores AE SEM for the first five study groups after observation of venules, arterioles, and both vessel types (composite). It should be noted that no vascular damage was observed for the control and BPD only groups. Intermediate levels of vascular damage were observed in the CW alone, CW þ PDL and BPD þ PDL groups. These study groups provide a source of comparison for the PDT, PDL alone and PDT þ PDL study groups whose results are described below. Table 3 provides the mean weighted damage scores AE SEM for the PDT, PDL alone, and PDT þ PDL study groups. PDT þ PDL resulted in significantly more severe vascular damage than any other study group: 127% more than PDT (P < 0.01), 47% more than PDL alone (P < 0.01). Analysis of variance (ANOVA) confirmed statistically significant differences between the groups (P < 0.01). 
RESULTS
DISCUSSION
In our study, the advantages of PDT þ PDL over either modality alone were demonstrated convincingly as combined therapies resulted in 127% more vascular injury than PDT (P < 0.01) and 47% more than PDL alone (P < 0.01). As such, the PDT þ PDL approach achieved synergism in this study.
Interestingly, the CW alone group was noted to produce vascular injury. We would have expected low level CW irradiation alone to have a minimal effect on the vasculature. This prediction appeared supported by the fact the damage scores of the CW þ PDL group were fairly similar to those of the PDL alone group. However, in light of the injury observed in the CW alone group, the effects of CW irradiation require further study.
It is very unlikely that the observed CW effects are due to thermal effects alone. Exposing the CAM vasculature to yellow light for Dt ¼ 125 seconds results in thermal diffusion over a distance L, given approximately by L ¼ ffiffiffiffiffiffiffiffi wDt p where the thermal diffusivity is w ¼ 1.2 Â 10 À7 m 2 /second [27, 28] . Heat will thus diffuse to a distance of about L ¼ 3.9 mm from the vessel during exposure. The corresponding heating of a single superficial vessel of diameter larger than the optical penetration depth in blood, is approximately DT : 2SDtD=rCpL 2 . The temperature rise DT in a vessel of diameter D ¼ 100 mm resulting from an irradiation S ¼ 60 W/cm 2 for 125 seconds exposure, and specific heat per unit volume rC ¼ 4.2 J/cm 3 8C, will thus be in the range of 0.018C. In the extreme case where the vessels cover the entire CAM surface in the area defined by the ring, the corresponding temperature rise will be about DT ¼ SDt=rCL, i.e., 0.48C. It may be concluded that the temperature rise is well below 18C and therefore, negligible.
Further evidence that the damage observed in the CW alone group is not due to thermal effects alone, is that the CW þ PDL group demonstrated approximately the same level of damage as the PDL alone group and significantly less that that observed for PDT þ PDL.
Histologically, PWS consist of dilated engorged capillaries with a single layer of endothelial cells [31] . Optical Doppler tomography (ODT) evaluation of vasculature during BPD-mediated sub-threshold PDT demonstrated transient changes, including vessel wall thrombus formation [22] . Because PWS vessels have been demonstrated to have venous characteristics, sub-threshold PDT induced thrombi are not likely to be subsequently dislodged by the low venous blood pressure present in PWS. It is also important to note that PDT, unlike PDL, affects all vessels including capillaries.
Yellow light emitted by the PDL is preferentially absorbed by hemoglobin in PWS allowing relatively selective (14) 3.5 AE 0.7 3.5 AE 0.6 3.9 AE 0.7 BPD þ PDL (14) 2.6 AE 0.6 2.4 AE 0.6 2.8 AE 0.6 n, number of CAM in each study group; BPD, benzoporphyrin derivative monoacid ring A; PDL, pulsed dye laser; CW, continuous wave irradiation. destruction of ectatic capillaries in the superficial dermis [32] . Heat induced by light absorption results in an intravascular coagulum [33] and endothelial cell damage [34] followed by hemorrhage and vasculitis [35] . One month after PDL treatment, abnormally dilated vessels are eliminated leaving small vessels with thickened endothelial walls [34] . These residual small vessels may, in some cases, contribute to incomplete PWS blanching.
By combining PDT-induced photochemical and PDLinduced photothermal injury, an enhanced effect can be achieved resulting in improved, yet still selective vascular injury and ultimately, we believe, optimized PWS blanching. Our technique uses a sub-therapeutic PDT exposure to create an initial vascular injury in blood vessel walls [22] , especially smaller vessels (potentially not affected by PDL alone). PDL irradiation immediately, or after a short interval following PDT, then heats selectively the pretreated vessels compromised by PDT. Use of yellow light for both PDT and PDL confines therapeutic effects to the upper 1,000 mm of the dermis, containing ectatic PWS venules, while reducing the risk of possible skin infarction which could result from destruction of the lower vascular plexus [36] .
We have initiated studies to evaluate the therapeutic efficacy of the PDT þ PDL approach for treatment of vascular lesions such as PWS in humans. Prior to clinical use for PWS, the complex nature of the response of human skin to photoactivated BPD must be elucidated with further studies devoted to structural changes produced in skin [14] [15] [16] [17] [18] . ODT can image blood flow in human skin with high (10 mm) spatial resolution [37] and will be used to monitor the response to sub-threshold PDT and PDL irradiation in-situ and in real time [37, 38] . This will enable optimization of PWS light exposure and allow determination of the treatment end point on an individual patient basis. Prospective, clinical studies are required so that the role of combined PDT þ PDL treatment in the clinical management of PWS patients can be fully defined.
